{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:53:32Z","timestamp":1781607212402,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>To present the clinical features and outcomes of treatment in von Hippel-Lindau (VHL) related retinal capillary hemangioblastoma (RCH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective interventional cohort study that included Patients who were diagnosed with VHL-related RCH from 2014 to 2024 at a tertiary referral center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-two eyes of 18 patients with VHL-associated RCH were included. Treatment was indicated in 30 eyes (90.9%), and the indications for treatment were tumor leakage and subretinal fluids (SRF) with or without exudative retinal detachments in 25 eyes (83.3%) and tractional\/exudative retinal detachments (T-ERD) in 4 eyes (13.3%). Significantly worse visual outcomes were observed in patients who had lower BCVA on presentation, larger tumor sizes, developed retinal complications, underwent retinal surgery, detached retina on the last follow up and had persistent tumor outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The management outcomes in VHL-related RCH depend on the lesionsize and location, severity of the clinical picture on presentation and the development of complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-025-00721-1","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T10:01:35Z","timestamp":1755511295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The clinical features and real world treatment outcomes in von Hippel Lindau related retinal capillary hemangioblastomas"],"prefix":"10.1186","volume":"11","author":[{"given":"Abdulrahman","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael A.","family":"Alsakran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman H.","family":"Badawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa S.","family":"Magliyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"721_CR1","doi-asserted-by":"publisher","unstructured":"Singh AD, Shields CL, Shields JA. von Hippel-Lindau disease. Surv Ophthalmol. 2001 Sep-Oct;46(2):117\u2009\u2013\u200942. https:\/\/doi.org\/10.1016\/s0039-6257(01)00245-4. PMID: 11578646.","DOI":"10.1016\/s0039-6257(01)00245-4"},{"key":"721_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF01994821","volume":"59","author":"E von Hippel","year":"1904","unstructured":"von Hippel E. U\u00a8 Ber eine Sehr Seltenen erkrankung der Netzhaut. Graefes Arch Ophthalmol. 1904;59:83\u2013106.","journal-title":"Graefes Arch Ophthalmol"},{"issue":"Suppl","key":"721_CR3","first-page":"1","volume":"1","author":"A Lindau","year":"1926","unstructured":"Lindau A. Studien u\u00a8ber kleinhirncysten. Bau, pathogenese und beziehungen Zur angiomatosis retinae. Acta Pathol Microbiol Scand. 1926;1(Suppl):1\u2013128.","journal-title":"Acta Pathol Microbiol Scand"},{"key":"721_CR4","doi-asserted-by":"publisher","unstructured":"Latif F, Tory K, Gnarra J et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260(5112):1317-20. https:\/\/doi.org\/10.1126\/science.8493574. PMID: 8493574.","DOI":"10.1126\/science.8493574"},{"key":"721_CR5","doi-asserted-by":"publisher","unstructured":"Iliopoulos O, Kibel A, Gray S, Kaelin WG Jr. Tumour suppression by the human von Hippel-Lindau gene product. Nat Med. 1995;1(8):822-6. https:\/\/doi.org\/10.1038\/nm0895-822. PMID: 7585187.","DOI":"10.1038\/nm0895-822"},{"key":"721_CR6","doi-asserted-by":"publisher","unstructured":"Maxwell PH, Wiesener MS, Chang GW et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399(6733):271-5. https:\/\/doi.org\/10.1038\/20459. PMID: 10353251.","DOI":"10.1038\/20459"},{"key":"721_CR7","doi-asserted-by":"publisher","unstructured":"Singh AD, Nouri M, Shields CL et al. Treatment of retinal capillary hemangioma. Ophthalmology. 2002;109(10):1799\u2009\u2013\u2009806. https:\/\/doi.org\/10.1016\/s0161-6420(02)01177-6. PMID: 12359597.","DOI":"10.1016\/s0161-6420(02)01177-6"},{"key":"721_CR8","doi-asserted-by":"publisher","unstructured":"Hardwig P, Robertson DM. von Hippel-Lindau disease: a familial, often lethal, multi-system phakomatosis. Ophthalmology. 1984;91(3):263\u2009\u2013\u200970. https:\/\/doi.org\/10.1016\/s0161-6420(84)34304-4. PMID: 6538954.","DOI":"10.1016\/s0161-6420(84)34304-4"},{"key":"721_CR9","doi-asserted-by":"publisher","unstructured":"Moore AT, Maher ER, Rosen P et al. Ophthalmological screening for von Hippel-Lindau disease. Eye (Lond). 1991;5 (Pt 6):723-8. https:\/\/doi.org\/10.1038\/eye.1991.133. PMID: 1800174.","DOI":"10.1038\/eye.1991.133"},{"key":"721_CR10","doi-asserted-by":"publisher","unstructured":"Webster AR, Maher ER, Moore AT. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol. 1999;117(3):371-8. https:\/\/doi.org\/10.1001\/archopht.117.3.371. PMID: 10088816.","DOI":"10.1001\/archopht.117.3.371"},{"issue":"2","key":"721_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/13816810.2014.886265","volume":"35","author":"E Wittstr\u00f6m","year":"2014","unstructured":"Wittstr\u00f6m E, Nordling M, Andr\u00e9asson S. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease. Ophthalmic Genet. 2014;35(2):91\u2013106. Epub 2014 Feb 20. PMID: 24555745.","journal-title":"Ophthalmic Genet"},{"issue":"12","key":"721_CR12","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1097\/IAE.0000000000002572","volume":"39","author":"HE Wiley","year":"2019","unstructured":"Wiley HE, Krivosic V, Gaudric A, Management of retinal hemangioblastoma in von hippel-lindau disease, et al. Retina. 2019;39(12):2254\u201363. https:\/\/doi.org\/10.1097\/IAE.0000000000002572. PMID: 31259811; PMCID: PMC6878154.","journal-title":"Retina"},{"key":"721_CR13","doi-asserted-by":"crossref","unstructured":"Krivosic V, Kamami-Levy C, Jacob J et al. Laser Photocoagulation for Peripheral Retinal Capillary Hemangioblastoma in von Hippel-Lindau Disease. Ophthalmol Retina. 2017 Jan-Feb;1(1):59\u201367. doi: 10.1016\/j.oret.2016.08.004. Epub 2016 Sep 12. PMID: 31047395.","DOI":"10.1016\/j.oret.2016.08.004"},{"key":"721_CR14","doi-asserted-by":"publisher","unstructured":"Krzystolik K, Stopa M, Kuprjanowicz L, Pars plana vitrectomy in advanced cases of von Hippel-Lindau eye disease. Retina. 2016;36(2):325\u2009\u2013\u200934. https:\/\/doi.org\/10.1097\/IAE.0000000000000707. PMID: 26308528.","DOI":"10.1097\/IAE.0000000000000707"},{"key":"721_CR15","doi-asserted-by":"publisher","unstructured":"Kim H, Yi JH, Kwon HJ et al. Therapeutic outcomes of retinal hemangioblastomas. Retina. 2014;34(12):2479-86. https:\/\/doi.org\/10.1097\/IAE.0000000000000254. PMID: 25072649.","DOI":"10.1097\/IAE.0000000000000254"},{"key":"721_CR16","doi-asserted-by":"publisher","unstructured":"Shields JA. Response of retinal capillary hemangioma to cryotherapy. Arch Ophthalmol. 1993;111(4):551. https:\/\/doi.org\/10.1001\/archopht.1993.01090040143049. PMID: 8470991.","DOI":"10.1001\/archopht.1993.01090040143049"},{"key":"721_CR17","doi-asserted-by":"publisher","unstructured":"Singh AD, Nouri M, Shields CL, Shields JA, Smith AF. Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease. Ophthalmology. 2001;108(10):1907-11. https:\/\/doi.org\/10.1016\/s0161-6420(01)00758-8. PMID: 11581072.","DOI":"10.1016\/s0161-6420(01)00758-8"},{"issue":"5","key":"721_CR18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ophtha.2023.12.014","volume":"131","author":"AB Daniels","year":"2024","unstructured":"Daniels AB, Chang EY, Chew EY, et al. Consensus guidelines for ocular surveillance of von Hippel-Lindau disease. Ophthalmology. 2024;131(5):622\u201333. https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.014. Epub 2023 Dec 12. PMID: 38092079.","journal-title":"Ophthalmology"},{"issue":"22","key":"721_CR19","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","volume":"385","author":"E Jonasch","year":"2021","unstructured":"Jonasch E, Donskov F, Iliopoulos O, et al. Belzutifan for renal cell carcinoma in von Hippel-Lindau disease. N Engl J Med. 2021;385(22):2036\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2103425. PMID: 34818478; PMCID: PMC9275515.","journal-title":"N Engl J Med"},{"key":"721_CR20","doi-asserted-by":"publisher","unstructured":"Wiley HE, Srinivasan R, Maranchie JK et al. Oral Hypoxia-Inducible Factor 2\u03b1 Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study. Ophthalmology. 2024;131(11):1324\u20131332. https:\/\/doi.org\/10.1016\/j.ophtha.2024.05.024. Epub 2024 Jun 6. Erratum in: Ophthalmology. 2025;132(3):374. doi: 10.1016\/j.ophtha.2024.12.032. PMID: 38849055.","DOI":"10.1016\/j.ophtha.2024.05.024"},{"key":"721_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ajo.2020.09.010","volume":"222","author":"SR Nowilaty","year":"2021","unstructured":"Nowilaty SR, Alsalamah AK, Magliyah MS, et al. Incidence and natural history of retinochoroidal neovascularization in enhanced S-Cone syndrome. Am J Ophthalmol. 2021;222:174\u201384. https:\/\/doi.org\/10.1016\/j.ajo.2020.09.010. Epub 2020 Sep 15. PMID: 32941856.","journal-title":"Am J Ophthalmol"},{"key":"721_CR22","doi-asserted-by":"publisher","unstructured":"Atebara NH. Retinal capillary hemangioma treated with verteporfin photodynamic therapy. Am J Ophthalmol. 2002;134(5):788\u2009\u2013\u200990. https:\/\/doi.org\/10.1016\/s0002-9394(02)01648-3. PMID: 12429270.","DOI":"10.1016\/s0002-9394(02)01648-3"},{"key":"721_CR23","doi-asserted-by":"publisher","unstructured":"Bunajem M, Magliyah M, Alzahrani Y. Intravitreal Triamcinolone Acetonide in Von Hippel\u2013Lindau Patient with Novel Mutation. Middle East African Journal of Ophthalmology 27(3):p 188\u2013190, Jul\u2013Sep. 2020. | https:\/\/doi.org\/10.4103\/meajo.MEAJO_216_20","DOI":"10.4103\/meajo.MEAJO_216_20"},{"issue":"2","key":"721_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10633-020-09787-8","volume":"142","author":"MS Magliyah","year":"2021","unstructured":"Magliyah MS, AlSulaiman SM, Schatz P, Nowilaty SR. Evolution of macular hole in enhanced S-cone syndrome. Doc Ophthalmol. 2021;142(2):239\u201345. https:\/\/doi.org\/10.1007\/s10633-020-09787-8. Epub 2020 Aug 19. PMID: 32815098.","journal-title":"Doc Ophthalmol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00721-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:06:49Z","timestamp":1781604409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-025-00721-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00721-1","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board (IRB) at King Khaled Eye Specialist Hospital (IRB number: RP 25078-R). This study adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}